In-silico studies, synthesis, and pharmacological screening of novel multitarget diphenylpyrazole scaffold as EGFR/BRAF and cyclooxygenase-2 inhibitors

Nature·Dec 23

This story is reported by Nature. Read what other outlets are saying below, then open the original report for full details.